Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2019-08-12 | 2019-08-29 | 91360 |
| LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2019-10-07 | 2019-10-19 | 95656 |
| LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2019-12-19 | 2020-04-08 | 101626 |
| LOSARTAN HCT | 12.5MG 50MG | TABLET | Actual shortage | 2021-10-15 | 2021-10-15 | 147427 |
| LOSARTAN HCT | 12.5MG 50MG | TABLET | Actual shortage | 2021-10-15 | 2021-10-15 | 147430 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-05-09 | 2022-05-25 | 160204 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-08-17 | 2022-09-30 | 166884 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Resolved | 2017-08-17 | 2017-11-24 | 19723 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Resolved | 2018-05-11 | 2018-07-23 | 49071 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Resolved | 2018-09-27 | 2019-03-06 | 62498 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |